Related Experiment Video
Updated: Sep 29, 2025

A Coregistered Ultrasound and Photoacoustic Imaging Protocol for the Transvaginal Imaging of Ovarian Lesions
Published on: March 3, 2023
An Unusual Presentation of a Corpus Luteum Rupture
Parth Godhiwala1, Himanshi Agarwal2, Sourya Acharya1
1Department of Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences (Deemed to be University), Wardha, Maharashtra, India.
Insights
Rheumatic heart disease patients on anticoagulants face rare gynecological bleeding risks. A case highlights ovulatory bleeding causing hemoperitoneum in a mitral valve replacement patient.
Area of Science:
- Cardiology
- Gynecology
- Hematology
Background:
- Rheumatic heart disease (RHD) is prevalent in India, often leading to mitral valve replacement (MVR).
- Anticoagulant therapy post-MVR increases the risk of drug-induced coagulopathy.
- Gynecological hemorrhage is a rare but serious complication in women of reproductive age on anticoagulants.
Observation:
- A 30-year-old woman with MVR on anticoagulants presented with congestive cardiac failure.
- Massive hemoperitoneum was diagnosed via ultrasound-guided paracentesis.
- Bleeding from a corpus luteal cyst, indicative of ovulatory bleeding, was identified as the cause.
Findings:
- The patient's ascites and hemoperitoneum were attributed to normal ovulatory bleeding.
- This rare complication underscores the interplay between cardiac management and gynecological events.
- Coagulopathy-related hemorrhage can manifest with significant intra-abdominal bleeding.
Implications:
- Highlights the need for vigilance regarding gynecological bleeding in women on anticoagulation post-MVR.
- Suggests considering ovulatory events as a potential cause of hemoperitoneum in at-risk patients.
- Emphasizes multidisciplinary management for complex cardiac and gynecological cases.
Abstract:
Rheumatic heart disease (RHD) is one of the most common cardiac conditions seen in India with mitral stenosis as the most prevalent cause affecting females more than males. With the increasing number of patients undergoing mitral valve replacement (MVR) and mandatory use of anticoagulants post-MVR, the patients presenting with drug-induced coagulopathy have increased. One of the rare complications of coagulopathy-related hemorrhage may be associated with a gynecological cause with maximum risk in women of reproductive age group. This chance of hemorrhage has increased due to various events that occur in reproductive organs, namely, ovulation, menstruation, trauma due to sexual intercourse, or pregnancy-related bleeding. Such bleeding is evident as external vaginal bleeding or hemoperitoneum. Hereby, we present a rare case of a 30-year-old woman, on anticoagulant therapy for MVR who presented with congestive cardiac failure associated with massive hemoperitoneum. On ultrasound-guided paracentesis, the cause of mild-to-moderate ascites was normal ovulatory bleed evident by the bleeding from the corpus luteal cyst.
More Related Videos
Related Concept Videos
Ovarian Cycle
Ovaries
On the ovarian surface, a layer of...
Secretory Phase
Following ovulation, the corpus luteum, a temporary endocrine structure, produces progesterone and estrogens. These hormones stimulate the growth and coiling of endometrial...
Uterus and Cervix
The uterus is securely anchored within the pelvic cavity by paired broad ligaments on either side. It is further stabilized by three pairs...

